Most common cause of valvular heart disease
Most common cause of valvular heart disease Valvular heart disease (VHD) refers to damage or defects of one or more of the heart’s valves, which can disrupt normal blood flow through the heart. Understanding the most common causes of VHD is essential for early diagnosis, management, and prevention strategies. Among various etiologies, rheumatic heart disease remains the predominant cause globally, especially in developing countries, though degenerative changes are more prevalent in developed nations.
Rheumatic heart disease is a consequence of rheumatic fever, an inflammatory disease that can develop after an untreated or inadequately treated streptococcal throat infection. This autoimmune response leads to inflammation and scarring of the heart valves, most commonly affecting the mitral valve but also involving the aortic valve. Over time, repeated episodes of rheumatic fever cause progressive damage, resulting in stenosis (narrowing) or regurgitation (leakage) of the affected valves. The pathophysiology involves immune-mediated destruction of the valvular tissue, leading to fibrosis and deformity.
In many parts of the world, rheumatic fever remains a significant health concern due to limited access to prompt antibiotic treatment for streptococcal infections. As a result, rheumatic heart disease remains the leading cause of valvular problems in regions such as Africa, Asia, and Latin America. Its prevalence underscores the importance of public health measures that promote early detection and treatment of streptococcal pharyngitis to prevent rheumatic fever and subsequent heart valve damage.
In contrast, degenerative valvular disease is more common in aging populations, particularly in developed countries. Age-related calcification and wear-and-tear lead to degeneration of the valves, especially the aortic and mitral valves. Calcific aortic stenosis is a hallmark of degenerative disease, characterized by calcium deposits on the valve leaflets that cause thickening and reduced mobility. Similarly, mitral annular calcification can impair valve function. These changes are often associated with comorbidities such as hypertension, hyperlipidemia, and chronic kidney disease.
Other causes of valvular disease include congenital abnormalities, infective endocarditis, and certain systemic diseases like connective tissue disorders (e.g., Marfan syndrome). Congenital malformations, such as bicuspid aortic valves, can lead to early degeneration or stenosis. Infective endocarditis, caused by bacterial or fungal infections, can damage valve structures, resulting in both acute and chronic valvular dysfunction.
In summary, while degenerative changes are becoming increasingly common in aging populations, rheumatic heart disease remains the most prevalent cause of valvular heart disease worldwide, especially in developing regions. Effective prevention through public health initiatives, early diagnosis, and timely treatment of streptococcal infections are crucial in reducing the burden of rheumatic valve disease. Advances in surgical and transcatheter interventions have also improved outcomes for patients with advanced valvular disease, emphasizing the importance of early detection and management.
